Cedrus Therapeutics

Cedrus Therapeutics is an early-stage German-American drug discovery and development company focused on novel therapeutics for neurodegenerative disease, neuroinflammatory disease, and oncology. Publicly available descriptions indicate programs or research interests spanning Alzheimer's disease, Parkinson's disease, multiple sclerosis, and cancer. The company appears to have remained private and unfunded, with limited recent public disclosure on specific assets, targets, or clinical development milestones. Available evidence suggests it was founded around 2008-2009 by Erich F. Greiner and has been associated with both U.S. and Hamburg, Germany addresses. Overall, Cedrus Therapeutics appears to be a small, private preclinical biotech with sparse public operating detail.